Profound Medical to Participate in the 2021 Bloom Burton & Co. Virtual Healthcare Investor Conference
14 avr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, April 14, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical Announces the Appointment of Cynthia Lavoie to its Board of Directors
03 mars 2021 07h00 HE
|
Profound Medical Corp.
TORONTO, March 03, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable,...
Profound Medical Announces Fourth Quarter and Full Year 2020 Financial Results
02 mars 2021 16h02 HE
|
Profound Medical Corp.
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
Profound Medical to Participate in March Virtual Investor Conferences
25 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Participate in the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
11 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical to Release Fourth Quarter and Full Year 2020 Financial Results on March 2 – Conference Call to Follow
09 févr. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2020 Revenues
05 janv. 2021 16h30 HE
|
Profound Medical Corp.
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound”), a commercial-stage medical device company that develops and markets customizable, incision-free...
Profound Medical Signs Agreement with GE Healthcare to Expand Provider Access to TULSA-PRO®
21 déc. 2020 07h30 HE
|
Profound Medical Corp.
TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...
Profound Medical Receives FDA HDE Approval for Sonalleve®
30 nov. 2020 08h00 HE
|
Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”) announced today that Sonalleve® has received U.S. Food and Drug Administration...
Profound Medical Announces Changes to its Board of Directors
30 nov. 2020 07h45 HE
|
Profound Medical Corp.
TORONTO, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which...